相关实验视频

Updated: Jul 2, 2025

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

在多发性骨髓瘤中优化CAR T细胞治疗经验:专家圆桌会议的临床珍珠

Sikander Ailawadhi¹, Leyla Shune², Sandy W Wong³

¹Division of Hematology/Oncology, Mayo Clinic, Jacksonville, FL.

Clinical lymphoma, myeloma & leukemia

|February 18, 2024

概括

化学抗原受体T细胞 (CAR-T) 疗法为多发性髓瘤 (MM) 提供了新的希望. 推和CAR-T中心医疗保健提供者 (HCP) 之间的早期合作对于优化患者选择和管理至关重要.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.

背景情况:

化学抗原受体T细胞 (CAR-T) 疗法代表了多发性骨髓瘤 (MM) 治疗的重大进展.
卡特-T治疗过程涉及基于众多变量的复杂决策.

研究的目的:

概述MM中CAR-T治疗的患者选择和管理.
从经验丰富的医疗保健提供者 (HCP) 的角度强调每个步骤的考虑因素.

主要方法:

对MM的CAR-T治疗现行实践和专家意见的审查.
分析患者选择标准,桥梁疗法和淋巴缺血疗法.

主要成果:

建议提前推并推医疗保健专家和CAR-T中心之间的沟通,特别是在服务不足或高风险人群中.
患者的选择应考虑表现状况,疾病进展和后勤因素.
桥梁疗法应该是个性化的,最好在CAR-T输注前至少一周停止;淋巴细胞减少可能需要修改功能不全.

结论:

优化MM的CAR-T治疗需要推和治疗医疗人员之间的协作护理.
在整个过程中,经验丰富的HCP指导对于改善患者的治疗结果至关重要,因为CAR-T的访问范围正在扩大.

关键词:

在CART-T中,我们可以使用CAR-T.这就是Cilta-cel.这是一个Ide-cel.复发性耐火多发性骨髓瘤复发性多发性骨髓瘤

更多相关视频

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...